PICTON PROPERTY INCOME LIMITED (PCTN) – Investment Research Note

Executive summary

Picton is a small internally-managed UK diversified REIT (£702m portfolio: 66% industrial/logistics, 21% office, 12% retail) that has delivered upper-quartile MSCI-relative property returns since 2005 but has persistently traded at a wide discount to EPRA NTA (101.5p vs. undisturbed price ~73.5p). On 31 July 2026 the Board unanimously recommended a firm all-share offer from a LondonMetric/SREIT consortium at 0.190 LondonMetric + 0.894 SREIT shares per Picton share, valuing PCTN at 78.7p/£404m — a scheme expected to become effective in early September 2026. The single most important valuation point today is that PCTN is a near-completion merger-arbitrage situation, not an operating company thesis: fair value is anchored by the offer terms and by NAV as a downside if the deal breaks.

Fair value estimate

Fair value range: 75p – 82p per share (implied mcap £383m – £419m).

Methodology: NAV-anchored with take-out arithmetic. The Board has agreed a firm scheme at 78.7p (as of 30 July 2026 reference prices), representing a 6.0% GAV discount and 8.2% NTA discount. The value received will float with LondonMetric and SREIT share prices between now and completion. Downside scenario (deal breaks): NAV was 101.5p at 30 June 2026 but the pre-announcement undisturbed price was ~73.5p and the 3-month VWAP was 71.6p, i.e. the market re-rated shares back to something close to the pre-deal discount to NAV. Upside scenario: superior competing bid — possible but not indicated; only 12% irrevocables plus board recommendation, so a counter-bidder could theoretically emerge.

• Mid fair value: ~78.5p (£401m), essentially the scheme value
• vs. current 71.60p (£373.3m): upside ~9.6% to mid
• vs. current mcap £373.3m: upside ~£28m absolute

The 9.6% spread to deal terms reflects (i) SREIT/LondonMetric share price drift since the reference date, (ii) time value to expected September 2026 completion, and (iii) residual deal risk (Court sanction, shareholder vote at 75% threshold).

Sector context

Confirmed: Real Estate — Diversified UK REIT. Picton's quality is in-line with the mid-cap diversified UK REIT peer group, with a slightly better long-run MSCI-relative track record but sub-scale liquidity that drove the persistent discount and ultimately the sale. Listed peers: LondonMetric (LMP), Schroder Real Estate Investment Trust (SREI) — both are the acquirers here — and Custodian Property Income (CREI). Leverage (24% LTV) is below sector average; debt cost (3.7% fixed to 2031/32) is well below current market rates and represents genuine hidden value (£22m fair-value benefit vs. book).

Investment thesis (at 71.60p)

1. Near-certain deal completion at ~78.7p equivalent value, providing ~10% upside on a c.5-week timeline: firm board recommendation, TR Property (11.67%) plus directors have provided irrevocables, Stifel Rule 3 opinion that terms are fair and reasonable, and completion targeted for early September 2026 2026-07-31 Rule 2.7 Announcement.
2. Downside partially cushioned by portfolio quality and long fixed-rate debt: 66% industrial exposure with rental reversion, EPRA NTA of 101.5p, £22m debt fair-value benefit, and a track record of MSCI outperformance for 13 consecutive years 2026-06-12 Preliminary Annual Results. NAV would only be realised through a break-up, but supports the case that a deal collapse would not send the stock to distressed levels.
3. Continued exposure post-completion to two better-capitalised platforms (LondonMetric FTSE 100 BBB+ NNN REIT; SREIT active management platform), with implied 39.4% pro-forma EPS accretion and 47.4% dividend uplift for holders who roll into the combined entities 2026-07-31 Rule 2.7 Announcement.

Key risks

1. Scheme fails at the Court Meeting (needs 75% by value, majority by number): shares would likely re-rate back toward pre-deal levels (~73.5p undisturbed) or lower given renewed strategic uncertainty. Only 12% irrevocables are in hand 2026-07-31 Rule 2.7 Announcement.
2. Consideration is scrip, not cash: value fluctuates with LondonMetric and SREIT share prices between announcement and completion. If either acquirer's share price falls materially (e.g. UK REIT sector sell-off, gilt spike), the realised value drops proportionately. Both LMP and SREI are also property-sensitive.
3. Underlying occupancy has weakened to 84% with two industrial break events (Rushden, Radlett) accounting for 40% of vacancy; not deal-relevant unless the scheme breaks, but this is the operating reality one would inherit in a break scenario, along with a well-covered but modest 0.69p permitted dividend 2026-07-31 Trading Update.

Operating leverage

Picton is a real estate company, not an operationally-leveraged business. The fixed-cost base is genuinely small — internalised management, ~12 employees, EPRA cost ratio 25% and Group cost ratio 1.3% 2026-06-12 Annual Results. Incremental rental income does drop through at a high marginal rate because central costs are largely fixed, but the total quantum is capped: the entire admin cost base is only £7m against £45m contracted rent, so full occupancy uplift (£8m of vacant ERV) would grow EPRA earnings by ~30-35%, not multiples. Contribution margin on incremental letting is high but the reversionary upside is quantified (£13.2m above current rent) and largely already reflected in NAV. This is not a business where a revenue surprise translates into multiples of profit — that dynamic requires operational gearing on a scaling revenue line, which a mature diversified property portfolio does not have.

Value-trap signals

1. Persistent share price discount to NAV that could not be closed via buybacks (£17.3m repurchased in FY26 at avg 77p, 25% discount) — this was itself the trigger for the Strategic Review 2026-01-13 Strategic Review.
2. Sub-scale — market cap of ~£373m has been sub-institutional, restricting the shareholder base and preventing equity raises since 2019 2026-01-13 Strategic Review.
3. Declining occupancy (94% → 84% over the year, with the two largest industrial voids each >40% reversionary but currently rent-losing) 2026-06-12 Annual Results.
4. Office sector remains structurally challenged (21% of portfolio); Picton has been selectively repositioning offices for alternative uses to exit the sector.

The Board's response — running a Formal Sale Process — has crystallised value at a moderate NTA discount, so the "trap" element has been addressed via the takeover.

Earnings vs. expectations

Picton does not issue formal earnings guidance and has limited sell-side coverage. EPRA EPS delivery has been broadly stable: FY24 4.0p → FY25 4.2p → FY26 4.0p (guided lower in FY26 owing to Rushden break and office vacancy). Dividend was increased 5.7% in April 2024 (to 3.7p) and 2.7% in May 2025 (to 3.8p), then reduced to 0.69p for Q1 FY27 as the Picton "Permitted Dividend" under the scheme. Pattern: broadly in-line with the company's own targets, no material profit warnings, but no meaningful analyst consensus to beat against — this is a not-enough-data case for surprise trend.

Conviction

4 — high. Anchors: (a) the fair value is defined by a firm, recommended, all-share scheme with clear economics and a documented timetable; (b) IFRS-audited NAV of 101.5p and independent CBRE/Knight Frank valuations provide a downside floor concept; (c) Rule 29 valuation reports will be published with the scheme document. Caveats: (i) consideration is scrip so the exact realised value will move with LMP and SREI prices; (ii) small residual risk the scheme is voted down or a superior offer emerges to change the arithmetic.

Overall score rationale

This is essentially a merger-arb position with ~10% upside to deal completion and modest downside if the scheme breaks. It has zero AI-receiver exposure, no operating leverage in the sense the user cares about, and the "growth" from here is capped at the scheme value. It scores in the low band of the framework — worth knowing about only as an income/arb name, not as a strategic fit.